Tag Archives: Johnson & Johnson
First Bellwether Trial in Risperdal Breast Enlargement Cases Scheduled for November Third
The first bellwether case in a group of lawsuits filed against Risperdal maker Johnson & Johnson is set to begin November 3 in the Philadelphia Court of Common Pleas Complex Litigation Center. The lawsuits allege that Risperdal was a defective product for its failure to warn of side effects, particularly gynecomastia, or the enlargement… Read More »
DePuy ASR Hip Replacement Settlement offers $250,000 Base Award to Eligible Patients: Amount can be increased or reduced depending on certain factors
The multi-billion dollar settlement entered into by the DePuy Orthopedics unit of Johnson & Johnson will compensate affected individuals with $250,000 each to cover the costs of revision surgeries and other complications derived from the implant of a DePuy ASR hip replacement. These hip replacement models have been shown to fail at an unacceptably… Read More »
